Related Experiment Video
Updated: Feb 1, 2026

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection
Published on: August 20, 2007
The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen
Xiaoqing Zheng1, Yifan Chen1, Man Bai1
1State Key Laboratory of Natural and Biomimetic Drugs, Peking University, No. 38, Xueyuan Road, Beijing 100191, PR China; Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Road, Beijing 100191, PR China.
Abstract:
Treating cancer metastasis is of vital importance to prolong patients' survival. Thioredoxin reductase (TrxR) is overexpressed in many cancer types and has been recognized as an anti-cancer target. The organoselenium compound ethaselen (BBSKE) has been proved to be a TrxR inhibitor and inhibit various types of tumor growth. However, whether BBSKE could inhibit tumor metastasis remains unclear. In this study, we aim to explore the antimetastatic effect of BBSKE and underlying mechanisms. BBSKE was found to dose-dependently suppress migration and invasion of MCF-7 and LoVo cells in vitro. The underlying mechanisms may include inhibition of TrxR activity, elevation of reactive oxygen species (ROS), decrease of EGFR activation and HER2 expression. Besides, the epithelial to mesenchymal transition process and expression of CD44, MMP-9, VEGFR2 and PD-L1 were also abrogated. Decreased migration and invasion, lower expression levels of EGFR, HER2, N-cadherin, CD44, MMP-9, VEGFR2 and PD-L1 were also observed in TrxR1-knockdown MCF-7 and LoVo cells. In the mouse breast cancer 4T1 model, BBSKE not only inhibited progression of primary tumor, but also suppressed formation of metastatic lung nodules and liver micro-metastases, indicating that BBSKE could effectively abolish tumor metastasis. In conclusion, our findings show that BBSKE is able to inhibit migration and invasion of cancer cells in vitro and in vivo, and may be used to prevent and treat metastasis.
Insights
Ethaselen (BBSKE), a thioredoxin reductase (TrxR) inhibitor, effectively suppresses cancer cell migration and invasion. This organoselenium compound shows promise in preventing and treating metastasis by targeting key molecular pathways.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Cancer metastasis significantly impacts patient survival.
- Thioredoxin reductase (TrxR) is overexpressed in many cancers, making it a viable anti-cancer target.
- Ethaselen (BBSKE), an organoselenium compound, is a known TrxR inhibitor with demonstrated tumor growth inhibition.
Purpose of the Study:
- To investigate the antimetastatic effects of ethaselen (BBSKE).
- To elucidate the underlying molecular mechanisms of BBSKE's antimetastatic action.
Main Methods:
- In vitro studies using MCF-7 and LoVo cancer cell lines to assess migration and invasion.
- In vivo studies using a mouse breast cancer (4T1) model.
- Analysis of TrxR activity, reactive oxygen species (ROS), EGFR activation, HER2 expression, epithelial-to-mesenchymal transition (EMT), and expression of metastasis-associated markers (CD44, MMP-9, VEGFR2, PD-L1).
- TrxR1-knockdown experiments in cancer cells.
Main Results:
- BBSKE dose-dependently inhibited cancer cell migration and invasion in vitro.
- Mechanisms involved TrxR inhibition, increased ROS, decreased EGFR activation, and reduced HER2 expression.
- BBSKE abrogated EMT and downregulated expression of CD44, MMP-9, VEGFR2, and PD-L1.
- In vivo, BBSKE inhibited primary tumor progression and suppressed lung and liver metastasis.
- TrxR1 knockdown mimicked the inhibitory effects of BBSKE on migration and invasion.
Conclusions:
- Ethaselen (BBSKE) demonstrates significant antimetastatic potential by inhibiting cancer cell migration and invasion.
- BBSKE acts through mechanisms including TrxR inhibition and modulation of key signaling pathways and EMT.
- BBSKE shows promise as a therapeutic agent for preventing and treating cancer metastasis.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
Mechanical Protein Functions
Dipeptidyl Peptidase 4 Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Mechanism of Conjugation

